Breaking News
March 26, 2019 - Using the Mastermind strategy in brain research
March 26, 2019 - Synthetic biological logic gate could one day be used to modify cellular function
March 26, 2019 - Researchers uncover large-scale brain patterns and networks which control sleep
March 26, 2019 - Scientific Symposium at LABVOLUTION focuses on key issues in life sciences
March 26, 2019 - Screen time plus snacking could increase risk for metabolic syndrome in teens
March 26, 2019 - Attention, Seniors: Drink More Water and Head Off Disease
March 26, 2019 - Peptide shows promise for protecting kidneys from nephritis
March 26, 2019 - Causes of diabetes decline or disappear when ‘zombie cells’ are removed, shows study
March 26, 2019 - Scientists identify common genetic variants associated with post-stroke recovery
March 26, 2019 - Study finds link between menopause and changes in body composition
March 26, 2019 - Higher levels of sex hormones in older men related to lower biological age
March 26, 2019 - Research links participation in team sports to larger hippocampal volumes in children
March 26, 2019 - Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent
March 26, 2019 - New technique measures frequency of sounds emitted from biological structures
March 26, 2019 - Removal of ‘zombie cells’ alleviates causes of diabetes in obese mice
March 26, 2019 - Women exposed to deepwater horizon oil spill continue to experience PTSD symptoms
March 26, 2019 - Shaping new treatments for tuberculosis
March 26, 2019 - Understanding genetic interactions holds key to new personalized therapies
March 26, 2019 - Nervous system relies on guidance cues for neuronal axons to reach destinations
March 26, 2019 - Altering gut microbiome may be potential treatment option for PCOS
March 26, 2019 - Moleculin Files with FDA for Expedited Approval Pathway for Annamycin
March 26, 2019 - GPs play pivotal role in ensuring success of new Faster Diagnosis Standard for Cancer
March 26, 2019 - New clues discovered to lung transplant rejection
March 26, 2019 - New study offers insight into development of delusions
March 26, 2019 - Children’s ball pits full of pathogenic microbes
March 26, 2019 - Exploring pathophysiological factors that link sleep problems and Alzheimer’s disease
March 26, 2019 - Walking downhill after meals can reduce bone resorption in postmenopausal women with diabetes
March 26, 2019 - USA LESS Issues Voluntary Nationwide Recall of LEOPARD Miracle Honey Due to Presence of Undeclared Sildenafil
March 26, 2019 - CT scan prior to spine fusion finds almost half of patients had undiagnosed osteoporosis
March 26, 2019 - After 2 Apparent Student Suicides, Parkland Grieves Again
March 25, 2019 - Inherited form of rickets improves more with new injectable medicine than conventional therapy
March 25, 2019 - Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
March 25, 2019 - Personal context directly affects CPAP use
March 25, 2019 - Mosquito tracking key to preventing disease outbreaks
March 25, 2019 - Scientists Detect Hidden Signals from Beneficial Bacteria
March 25, 2019 - Treating women with thyroid antibodies with Levothyroxine do not increase live birth rate
March 25, 2019 - Brain area that only processes spoken, not written words identified
March 25, 2019 - Race and ethnicity influence fracture risk in diabetic patients
March 25, 2019 - Researchers report new regenerative medicine approach for treating osteoarthritis of the knee
March 25, 2019 - Exposure to dim light at night may contribute to spread of breast cancer to bones
March 25, 2019 - Benefits of osteoporosis treatment in postmenopausal women outweigh the perceived risks
March 25, 2019 - Researchers find evidence of Cryptosporidium parasite in Minnesota’s public water systems
March 25, 2019 - Three Clues to Raised Risk of Miscarriage
March 25, 2019 - Structured play helps toddlers self-regulate, altering their life course
March 25, 2019 - Translating horror into justice: Stanford psychiatrist advocates for human rights
March 25, 2019 - HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range
March 25, 2019 - Recurrent pregnancy loss may be caused by sperm DNA damage, finds study
March 25, 2019 - Special Collection tracks development of new diagnostic tests for tuberculosis
March 25, 2019 - Air Force develops genetic test to predict mental performance
March 25, 2019 - To abort or not to abort—making difficult choices alone
March 25, 2019 - Computer vision technology could aid ICU care by spotting movement
March 25, 2019 - IONTAS wins ‘Small Business of the Year’ category at Cambridge News Business Excellence Awards 2019
March 25, 2019 - First postpartum depression drug gets FDA nod
March 25, 2019 - Research Recognition Award will help improve lives of young people with absence epilepsy
March 25, 2019 - Bisphosphonates to treat osteoporosis appears to be beneficial for all women
March 25, 2019 - Time-restricted eating may prove to be a dietary intervention against breast cancer
March 25, 2019 - Researchers develop new augmented reality app to assess spatial memory
March 25, 2019 - Dolomite Bio releases new Drop-seq datasets for single-cell RNA sequencing
March 25, 2019 - Hemoglobin A1c blood test may underestimate prevalence of diabetes
March 25, 2019 - Immune system errors linked to development of childhood leukemia
March 25, 2019 - Eating leafy green vegetables may help maintain muscle strength and mobility
March 25, 2019 - BMA secures state-backed clinical negligence indemnity scheme for GP trainees
March 25, 2019 - Biohaven Announces Completion of Pre-NDA Meeting With FDA for Oral CGRP Receptor Antagonist Rimegepant
March 25, 2019 - Adding breakfast to classrooms may have a health downside
March 25, 2019 - She Was Dancing On The Roof And Talking Gibberish. A Special Kind Of ER Helped Her.
March 25, 2019 - KNAUER introduces new Sepapure FPLC columns and media for protein purification tasks
March 25, 2019 - Weight loss in obese migraine sufferers can improve their quality of life
March 25, 2019 - Exposure to particulate air pollution may lead to reduced sperm production
March 25, 2019 - Synthetic peptide appears to disrupt inflammation and protect kidneys from nephritis
March 25, 2019 - New guideline focuses on strategies to improve health of older adults with diabetes
March 25, 2019 - Study evaluates prescribing of preventive drugs at the end of life in older adults with cancer
March 25, 2019 - Radial or femoral approaches for PCI are equal in terms of survival in heart attack patients
March 25, 2019 - Study shows how some autoimmune diseases are more closely related than others
March 25, 2019 - Long term opioid medications impacts production of important hormones
March 25, 2019 - FDA Issues Complete Response Letter for Zynquista (sotagliflozin)
March 25, 2019 - CDC researchers report on trends in hospital breastfeeding policies
March 25, 2019 - States Push For Caregiver Tax Credits
March 25, 2019 - Females on ketogenic diet fail to show metabolic benefits in animal model
March 25, 2019 - Modulating stiffness of blood-forming stem cells could facilitate mobilization procedures
March 25, 2019 - Gene editing regulations to be tightened
Single PSA Test Fails to Reduce Prostate Ca Deaths

Single PSA Test Fails to Reduce Prostate Ca Deaths

image_pdfDownload PDFimage_print

Action Points

  • One-time screening with a prostate-specific antigen (PSA) test failed to reduce prostate cancer deaths at 10 years, according to results of a randomized trial including over 400,000 British men in 573 primary care practices.
  • Recognize that screening for prostate cancer using PSA tests remains controversial, as the potential benefits of disease detection in its early stages can be outweighed by harms from overtreatment.

One-time screening with a prostate-specific antigen (PSA) test failed to reduce prostate cancer deaths at 10 years, despite an uptick in diagnoses of the disease, according to results of a randomized trial that included over 400,000 British men.

During the trial, 549 of 189,386 patients in the screening arm died from prostate cancer (0.30 per 1,000 person-years) compared with 647 of 219,439 patients in the control arm (0.31 per 1,000 person-years) for a rate ratio of 0.96 (P=0.50).

“The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) was designed to determine the effects of a low-intensity, single invitation PSA test,” wrote Richard M. Martin, PhD, of the University of Bristol, England, in JAMA. “Although longer-term follow-up is under way, the findings do not support single PSA testing for population-based screening.”

The trial included 419,582 men ages 50 to 69 screened at 573 primary care practices across the United Kingdom. Patients were recruited beginning in 2001, with follow-up concluding in 2016.

While no reduction in deaths due to prostate cancer were seen among screened patients, more cases of the disease were diagnosed in men receiving a PSA test (4.3%) compared with unscreened patients (3.6%). More tumors with a Gleason score of 6 or lower were identified in the screened group compared with the control group (1.7% versus 1.1%, respectively).

Localized disease (stage T1 or T2 cancer) was diagnosed at a more frequent rate in the screened group (2.6% versus 1.9% in the control group); in turn, fewer cases of advanced-stage cancer were diagnosed in this group (0.5% versus 0.6% in the control group).

Of the 549 men who died of prostate cancer in the screening group, only 188 had visited the clinic for PSA testing. Lethal cancer was diagnosed in 59 of these 188. Of the remaining 129 patients:

  • 68 were ineligible for prostate biopsy due to a PSA level less than 3.0 ng/mL,
  • 42 did not undergo PSA testing despite having attended the clinic,
  • 15 men had a PSA level 3.0 ng/mL or higher yet did not undergo a biopsy,
  • and 4 men had a benign biopsy.

In the all-cause mortality analysis, 25,459 died in the intervention group compared with 28,306 in the control group for a RR of 0.99 (P=0.49).

Screening for prostate cancer using PSA tests remains controversial, as the potential benefits of disease detection in its early stages can be outweighed by harms from overtreatment. In 2012, the U.S. Preventive Services Task Force (USPSTF) recommended against routine PSA screening for men of any age, but in 2017 adjusted this recommendation and now support an individualized approach to screening for men ages 55 to 69.

“It has been hypothesized that screening men in their early 50s may be more effective than at a later age,” the authors wrote. “However, we did not find statistical evidence to support this.”

In terms of adherence to screening, 75,707 patients (40%) of the 189,386 men assigned to the intervention arm attended the clinic for PSA testing; 67,313 of these men underwent PSA testing. High PSA levels — 3.0 ng/mL to 19.9 ng/mL — were detected in 6,857 patients and 5,850 underwent a biopsy.

In an editorial accompanying the article, Michael J. Barry, MD, of Harvard Medical School and Massachusetts General Hospital in Boston, wrote: “A key question is whether the findings from the CAP trial should swing the pendulum further in the direction of not offering screening PSA tests. Based on the CAP results, an offer of a single PSA screen in a population of men aged 50 to 69 years is ineffective, and given the higher risk of a prostate cancer diagnosis this approach engenders, likely does more harm than good.”

Barry, who is a member of the USPSTF, added that while further follow-up from CAP could potentially reveal benefit, based on the evidence so far “that eventuality seems unlikely.”

Martin and co-authors reported no conflicts of interest. Barry is chief science officer at Healthwise, and grants from the company have been awarded to Massachusetts General Hospital.

The CAP trial was funded by grants from Cancer Research U.K., and partial funding was provided by the U.K. Department of Health, National Institute of Health Research.

2018-06-03T00:00:00-0400

last updated

Tagged with:

About author

Related Articles